WAe001-A-31

H1_RB1ex1_D6

General

Cell Line

hPSCreg name WAe001-A-31
Cite as:
WAe001-A-31 (RRID:CVCL_XC42)
Alternative name(s)
H1_RB1ex1_D6
Cell line type Human embryonic stem cell (hESC)
Similar lines
WAe001-A-10
(H1_RB1ex3_G3)
WAe001-A-11
(H1_RB1ex3_G4)
RUCDRi002-A-63
(LVIP05-RB1-CS1)
WAe001-A
(WA01, H1)
WAe009-A-12
(H9_RB1ex3_C7)
WAe009-A-13
(H9_RB1ex3_G12LS)
WAe001-A-32
(H1_RB1ex1_E9)
WAe001-A-76
(H1-RNF1-/-)
WAe001-A-A
(H1X-10/H1.2-20)
WAe001-A-2B
(H1-NSD2-/-)
WAe001-A-B
(H1X-59/H1.2-6)
WAe001-A-C
(H1X-10/H1.3-62)
WAe001-A-D
(H1X-59/H1.3-68)
WAe001-A-E
(H1X-10/H1.4-4)
WAe001-A-F
(H1X-59/H1.4-5)
WAe001-A-86
(H1.139, H1.1-39)
WAe001-A-72
(H1-FTO-Knockout-13)
WAe001-A-87
(H1.213, H1.2-13)
WAe001-A-G
(H1X-10/H1.5-1)
WAe001-A-88
(H1.2-124, H1.2124)
WAe001-A-1N
(H1-FIS1-KO, WA01-FIS1-KO)
WAe001-A-89
(H1.3-64, H1.364)
WAe001-A-H
(H1X-59/H1.5-33)
WAe001-A-1O
(WA01-MYB-KO, H1-MYB-KO)
WAe001-A-77
(H1 RYBP-FLAG-HA KI)
WAe001-A-90
(H1.3-191, H1.3191)
WAe001-A-I
(H1.0-29/H1.1-13)
WAe001-A-41
(H1-RNF2-KO-1#)
WAe001-A-J
(H1.0-102/H1.1-34)
WAe001-A-42
(H1-RNF2-KO-2#)
WAe001-A-K
(H1.0-29/H1.2-31)
WAe001-A-1
(H1.1, WA01.1)
WAe001-A-L
(H1.0-102/H1.2-6)
WAe001-A-M
(H1.0-29/H1.3-22)
WAe001-A-N
(H1.0-102/H1.3-90)
WAe001-A-91
(H1.4-126, H1.4126)
WAe001-A-O
(H1.0-29/H1.4-14)
WAe001-A-92
(H1.4-143, H1.4143)
WAe001-A-P
(H1.0-102/H1.4-19)
WAe001-A-93
(H1.5-23, H1.523)
WAe001-A-78
(H1X10, H1X-10)
WAe001-A-94
(H1.528, H1.5-28)
WAe001-A-Q
(H1.0-29/H1.5-6)
WAe001-A-73
(H1-GATAD2B-KO-79#)
WAe001-A-R
(H1.0-102/H1.5-44)
Last update 24th February 2020
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Universität Duisburg-Essen (UDE)
Derivation country Germany

External Databases

Cellosaurus CVCL_XC42
BioSamples SAMEA6877446
Wikidata Q98134704

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity N/A

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Family history NO
Is the medical history available upon request? NO
Is clinical information available? NO

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor
All cell lines of this donor's relatives

External Databases (Donor)

BioSamples SAMEA7767418

Ethics

Also have a look at the ethics information for the parental line WAe001-A .
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hESC Derivation

The source cell information can be found in the parental cell line WAe001-A.

Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Passage method Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
SOX2
Yes
SSEA-4
Yes
TRA 1-60
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
CXCR4
Yes
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
CXCR4
Yes
TBXT
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
PAX6
Yes
NES
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
OMIM #180200
Synonyms
  • RB
  • retinoblastoma
  • RETINOBLASTOMA, MALIGNANT
  • Retinoblastoma
  • Retinoblastoma, NOS
show more synonyms
Genetic modifications
RB1 (target)
Gene knock-out
13q14.2
Cell line carries deletion of RB1 exon1/promoter on both alleles. Allele 1: Deletion of 400 nucleotides Allele 2: Deletion of 415 nucleotides
CRISPR-associated (CRISPR/Cas) System